Biogen Inc.BIIBNASDAQ
Loading
EBITDA Margin Over TimeStable
Percentile Rank14
3Y CAGR-3.1%
5Y CAGR-3.6%
Year-over-Year Change
EBITDA as a percentage of revenue
3Y CAGR
-3.1%/yr
vs -9.6%/yr prior
5Y CAGR
-3.6%/yr
Consistent
Acceleration
+6.5pp
Accelerating
Percentile
P14
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
2 yr
Consecutive growthStable
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 31.60% | +2.1% |
| 2024 | 30.96% | +28.1% |
| 2023 | 24.17% | -30.5% |
| 2022 | 34.77% | -2.7% |
| 2021 | 35.73% | -6.0% |
| 2020 | 38.00% | -29.4% |
| 2019 | 53.83% | +3.2% |
| 2018 | 52.14% | -3.1% |
| 2017 | 53.84% | -2.9% |
| 2016 | 55.43% | - |